Clinical Trials Logo

Clinical Trial Summary

This study involves both the development of a novel learning tool, the Radiation Treatment Plan Evaluation Learning Module, as well as a pilot program to validate this tool as an effective resource to teach treatment plan review and optimization to radiation oncology residents.


Clinical Trial Description

This study involves both the development of a novel learning tool, the Radiation Treatment Plan Evaluation Learning Module, as well as a pilot program to validate this tool as an effective resource to teach treatment plan review and optimization to radiation oncology residents. Stud procedures include screening for eligibility and completion of surveys and oncology examinations. Participation is expected to last about 6-8 weeks. It is expected about 20 radiation oncology resident physicians will participate in the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06115811
Study type Interventional
Source Massachusetts General Hospital
Contact Rachel Jimenez, MD
Phone 617-726-8651
Email RBJIMENEZ@PARTNERS.ORG
Status Not yet recruiting
Phase N/A
Start date January 15, 2024
Completion date September 1, 2025

See also
  Status Clinical Trial Phase
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT03734952 - Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant Chemoradiotherapy N/A
Recruiting NCT05176964 - Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer
Recruiting NCT03466424 - Short-course Radiotherapy (5×6Gy/7Gy/8Gy) Followed by Neo-adjuvant Chemotherapy for Locally Advanced Rectal Cancer